Medications starting with
Poland-
This is an antihypertensive drug used in the treatment of high blood pressure (arterial hypertension).
Dosage form: tablets, film-coated
Active substance Dosage perindopril arginine 5 mg indapamide 1.25 mg amlodipine 5 mg ATC code: C09BX01
Manufacturer: Actavis Ltd.
-
Poltriq is used to treat high blood pressure (arterial hypertension).
Dosage form: tablets, film-coated
Active substance Dosage perindopril arginine 10 mg indapamide 2.5 mg amlodipine 10 mg ATC code: C09BX01
Manufacturer: Actavis Ltd.
-
The medicine is used to treat high blood pressure (arterial hypertension).
Dosage form: tablets, film-coated
Active substance Dosage perindopril arginine 10 mg indapamide 2.5 mg amlodipine 5 mg ATC code: C09BX01
Manufacturer: Actavis Ltd.
-
This is an antihypertensive drug used in the treatment of high blood pressure (arterial hypertension).
Dosage form: tablets, film-coated
Active substance Dosage perindopril arginine 5 mg indapamide 1.25 mg amlodipine 10 mg ATC code: C09BX01
Manufacturer: Actavis Ltd.
-
The medicine is used to relieve the symptoms of schizophrenia in adults (over 18 years old) and in adolescents aged 13–17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 18.6 mg ATC code: N05AE05
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used to relieve symptoms of schizophrenia in adults (over 18 years old) and in adolescents aged 13–17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 74.5 mg ATC code: N05AE05
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used to relieve the symptoms of schizophrenia in adults and adolescents aged 13–17 years.
Dosage form: tablets, film-coated
Active substance Dosage lurasidone 37.2 mg ATC code: N05AE05
Manufacturer: Laboratorios Liconsa S.A.
-
The medicinal product is used in the treatment of Ménière's disease (characterized by dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 8 mg ATC code: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
The medicine is used in the treatment of Ménière's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 16 mg ATC code: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
It is used in the treatment of Ménière's disease (manifesting as dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.
Dosage form: tablets
Active substance Dosage betahistine dihydrochloride 24 mg ATC code: N07CA01
Manufacturer: Catalent Germany Schorndorf GmbH
-
The vaccine is used for prophylaxis in the case of recurrent respiratory tract infections in children aged 2 to 14 years and in adults.
Dosage form: suspension for injection
Active substance Dosage haemophilus influenzae 100 million cells staphylococcus aureus 500 million cells streptococcus pneumoniae 100 million cells moraxella catarrhalis 100 million cells staphylococcus epidermidis 500 million cells streptococcus pneumoniae 100 million cells klebsiella pneumoniae 100 million cells corynebacterium pseudodiphtheriticum 200 million cells escherichia coli 200 million cells streptococcus salivarius 100 million cells ATC code: J07AX
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used prophylactically in cases of recurrent respiratory tract infections in children aged 2 to 14 years and in adults.
Dosage form: suspension for injection
Active substance Dosage streptococcus salivarius 10 million cells streptococcus pneumoniae 10 million cells haemophilus influenzae 10 million cells staphylococcus epidermidis 50 mln. cells corynebacterium pseudodiphtheriticum 20 mln. cells escherichia coli 20 mln. cells staphylococcus aureus 50 mln. cells klebsiella pneumoniae 10 million cells moraxella catarrhalis 10 million cells streptococcus pyogenes 10 million cells ATC code: J07AX
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used prophylactically to prevent recurrent upper respiratory tract infections in children (from 6 months of age), adolescents, and adults.
Dosage form: drops nasal suspension
Active substance Dosage haemophilus influenzae 10 million cells streptococcus pneumoniae 10 million cells klebsiella pneumoniae 10 million cells staphylococcus aureus 50 mln. cells staphylococcus epidermidis 50 mln. cells corynebacterium pseudodiphtheriticum 20 mln. cells escherichia coli 20 million cells streptococcus pyogenes 10 million cells streptococcus salivarius 10 million cells moraxella catarrhalis 10 million cells ATC code: J07AX
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used for the prevention of recurrent respiratory tract infections in children aged 2 to 14 years and in adults.
Dosage form: suspension for injection
Active substance Dosage klebsiella pneumoniae 1 million cells staphylococcus aureus qs staphylococcus epidermidis up to 1 ml streptococcus salivarius 1 million cells streptococcus pneumoniae 1 million cells streptococcus pyogenes 1 million cells escherichia coli 2 million cells haemophilus influenzae 1 million cells corynebacterium pseudodiphtheriticum 2 million cells moraxella catarrhalis 1 million cells ATC code: J07AX
Manufacturer: Biomed - Kraków Vaccine and Serum Manufacturing Plant
-
The medicinal product is used in adults for the treatment of multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.
-
The medicinal product is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.
-
The medicine is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.
-
The medicine is used in adults with multiple myeloma (a type of white blood cell cancer). It is used in combination with other medicines, such as bortezomib and dexamethasone, or solely with dexamethasone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica S.A.
-
The medicine is intended for adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults with multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults to treat multiple myeloma. It may be taken in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.
-
The medicine is intended for the treatment of adults with multiple myeloma (a type of white blood cell cancer). It is used in combination with other medicines, such as bortezomib and dexamethasone, or alone with dexamethasone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Glenmark Pharmaceuticals s.r.o., Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma (a type of malignant tumor). It may be taken alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: AS Grindeks
-
This medicine is used in adults with multiple myeloma (a type of malignant tumor that affects blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to the tumor.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: AS Grindeks
-
The medicine is used in adults with multiple myeloma (a type of malignant tumor that affects blood cells). It is used in combination with other medicines, such as bortezomib and dexamethasone, or solely with dexamethasone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: AS Grindeks
-
The medicinal product is used in adults for the treatment of multiple myeloma (a type of malignant neoplasm). It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: AS Grindeks
-
The medicine is used in adults with multiple myeloma (a type of malignant cancer of the white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to them.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Pharmadox Healthcare Limited
-
The medicine is used in adults with multiple myeloma. It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to tumor cells.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Pharmadox Healthcare Limited
-
It is used in adults with multiple myeloma (a type of malignant cancer of the white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict the blood supply to them.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: Pharmadox Healthcare Limited
-
The medicine is used in adults with multiple myeloma (a type of malignant tumor that attacks white blood cells). It may inhibit tumor growth, stimulate the immune system to fight cancer cells, or restrict blood supply to them.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: Pharmadox Healthcare Limited
-
This medicine is used in adults to treat multiple myeloma. It may be administered in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicinal product is used in adults for the treatment of multiple myeloma. It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
This medicine is intended for the treatment of adults with multiple myeloma. It is used in combination with other medicines (bortezomib and dexamethasone or dexamethasone alone) to inhibit the growth of the cancer.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
This medicine is used in adults to treat multiple myeloma. It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults for the treatment of multiple myeloma (a type of malignant cancer that attacks white blood cells). It is used in combination with other medicines, such as bortezomib or dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Adalvo Limited Pharmadox Healthcare Limited Qualimetrix S.A.
-
The medicine is used in adults with multiple myeloma (a type of malignant tumor that affects white blood cells).
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Adalvo Limited Pharmadox Healthcare Limited Qualimetrix S.A.
-
The medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults with multiple myeloma, a type of malignant tumor that affects white blood cells.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
This medicine is used in adults to treat multiple myeloma (a type of malignant cancer that affects white blood cells). It may be used alone with dexamethasone or in combination with two other medicines: bortezomib and dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
This medicine is used in adults with multiple myeloma. It may be administered alone with dexamethasone or in combination with two other medicines (bortezomib and dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: Salutas Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
This medicine is used in adults to treat multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC code: L04AX06
Manufacturer: Adalvo Limited
-
The medicine is used in adults for the treatment of multiple myeloma (a type of malignant tumor that attacks white blood cells). It may be used alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC code: L04AX06
Manufacturer: Adalvo Limited
-
The medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC code: L04AX06
Manufacturer: Adalvo Limited
-
This medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be used in combination with other medicines, such as bortezomib and dexamethasone, or with dexamethasone alone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC code: L04AX06
Manufacturer: Adalvo Limited
-
The medicine is used for the prevention and treatment of many types of fungal infections (including Aspergillus, Fusarium, Coccidioides, as well as chromoblastomycosis and phaeohyphomycosis). It may also be used prophylactically in individuals at high risk of infection, e.g., due to chemotherapy or after bone marrow cell transplantation.
Dosage form: solution for infusion, concentrate
Active substance Dosage posaconazole 300 mg ATC code: J02AC04
Manufacturer: Pharmadox Healthcare Ltd.
-
The medicine is used to prevent and treat many types of fungal infections in adults and children over 2 years of age. It may be used to treat infections caused by fungi of the genera Aspergillus, Fusarium, and Coccidioides, as well as in cases of chromoblastomycosis and phaeohyphomycosis. It is also used prophylactically in individuals at high risk of infection, e.g., in patients with a weakened immune system following chemotherapy or bone marrow transplant.
Dosage form: solution for infusion, concentrate
Active substance Dosage posaconazole 300 mg ATC code: J02AC04
Manufacturer: Altan Pharmaceuticals S.A.
-
The medicine is used to prevent and treat many types of fungal infections. It may be used to treat specific infections (e.g., caused by Aspergillus, Fusarium, or Candida) or prophylactically in individuals at high risk of developing such infections, for example, due to a weakened immune system.
Dosage form: suspension, oral
Active substance Dosage posaconazole 40 mg/ml ATC code: J02AC04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicinal product is used to prevent and treat many types of fungal infections. In adults, it is used to treat infections caused by fungi of the Aspergillus, Fusarium, and Coccidioides genera, and in the treatment of diseases such as chromoblastomycosis and sporotrichosis. It may also be used prophylactically in individuals at high risk of infection, e.g., in patients with a weakened immune system following chemotherapy or bone marrow transplantation.
Dosage form: tablets, enteric-coated
Active substance Dosage posaconazole 100 mg ATC code: J02AC04
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicine is used to prevent and treat many types of fungal infections in adults. It may be used to treat specific infections (e.g., caused by Aspergillus, Fusarium, or Candida fungi) or prophylactically in individuals at high risk of infection, such as those with a weakened immune system.
Dosage form: suspension, oral
Active substance Dosage posaconazole 40 mg/ml ATC code: J02AC04
Manufacturer: Genepharm S.A., Glenmark Pharmaceuticals s.r.o., Rafarm S.A.
-
The medicine is used to prevent and treat many types of fungal infections. In adults, it is used to treat infections caused by fungi of the genera Aspergillus, Fusarium, and Coccidioides, as well as diseases such as chromoblastomycosis and maduromycosis. It may also be used prophylactically in individuals at high risk of infection, e.g., in patients with a weakened immune system following chemotherapy or after hematopoietic stem cell transplantation.
Dosage form: tablets, enteric-coated
Active substance Dosage posaconazole 100 mg ATC code: J02AC04
Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited